Differential Expression of C-kit and CD43 in Histological Subtypes of Adenoid Cystic Carcinoma of Salivary Gland

Overview

Journal Saudi Dent J

Specialty Dentistry

Date 2013 Aug 21

PMID 23960476

Citations 3

Authors

Mohamed M Ahmed

Eman A Abo-Hager

Affiliations

Soon will be listed here.

Abstract

Unlabelled: Adenoid cystic carcinoma (ACC) of the salivary gland is characterized by a prolonged but inevitably unfavorable clinical course. Recent studies have suggested that the transmembrane tyrosine kinase receptor, c-kit proto-oncogene is involved in ACC pathogenesis. CD43 is a sialoglycoprotein that is typically expressed by hematopoietic cells and their derivative neoplasms, although positivity in epithelial tumors has only been recognized recently.

Objective: The aim of this study was to evaluate c-kit and CD43 immunoreactivity in ACCs and to compare the extent of their expression in various histologically defined subgroups of ACC, and their probable involvement in ACC pathogenesis.

Study Design: Formalin-fixed paraffin-embedded sections from 35 ACCs were immunostained for c-kit and CD43 using monoclonal antibodies.

Results: Cytoplasmic and membranous c-kit immunoreactivity was detected in 25/35 ACCs (71.4%) with strong immunostaining observed in solid pattern of ACC. Cytoplasmic and membranous CD43 immunoreactivity was detected in 18/35 (51.4%) of ACCs with strong immunostaining seen in the cribriform pattern.

Conclusions: These results suggested that c-kit could be used as a prognostic marker for ACC and specific c-kit tyrosine kinase inhibitors such as imatinib, might be used in future therapeutic approaches against subgroups of ACC. CD43 appears to be preferentially expressed in salivary gland ACCs. Its expression decreased with cellular dedifferentiation and there was an inverse relationship between immunoexpression of c-kit and CD43 among ACC of salivary gland.

Citing Articles

Diagnostic reliability of c-KIT (CD117) in salivary gland tumours - A systematic review and meta-analysis.

Vijayakumar G, Kamboj M, Narwal A, Sharma G J Oral Maxillofac Pathol. 2024; 28(1):11-20.

PMID: 38800447 PMC: 11126241. DOI: 10.4103/jomfp.jomfp_70_24.

Adenoid cystic carcinoma of the right main bronchus showing squamous differentiation and mimicking mucoepidermoid carcinoma: a case report.

Tajima S, Koda K Int J Clin Exp Pathol. 2015; 8(5):5830-6.

PMID: 26191305 PMC: 4503176.

Adenoid cystic carcinoma of the buccal mucosa: A case report and review of the literature.

Ajila V, Hegde S, Nair G, Babu S Dent Res J (Isfahan). 2013; 9(5):642-6.

PMID: 23559934 PMC: 3612206. DOI: 10.4103/1735-3327.104888.

References

Petruch U, Horny H, Kaiserling E . Frequent expression of haemopoietic and non-haemopoietic antigens by neoplastic plasma cells: an immunohistochemical study using formalin-fixed, paraffin-embedded tissue. Histopathology. 1992; 20(1):35-40. DOI: 10.1111/j.1365-2559.1992.tb00913.x. View

Ziprin P, Alkhamesi N, Ridgway P, Peck D, Darzi A . Tumour-expressed CD43 (sialophorin) mediates tumourmesothelial cell adhesion. Biol Chem. 2004; 385(8):755-61. DOI: 10.1515/BC.2004.092. View

Woo V, Bhuiya T, Kelsch R . Assessment of CD43 expression in adenoid cystic carcinomas, polymorphous low-grade adenocarcinomas, and monomorphic adenomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 102(4):495-500. DOI: 10.1016/j.tripleo.2005.08.038. View

Edwards P, Bhuiya T, Kelsch R . C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003; 95(5):586-93. DOI: 10.1067/moe.2003.31. View

Izquierdo M, van der Valk P, Rubio G, Germa-Lluch J, Ueda R, Scheper R . Differential expression of the c-kit proto-oncogene in germ cell tumours. J Pathol. 1995; 177(3):253-8. DOI: 10.1002/path.1711770307. View

Fletcher J . Role of KIT and platelet-derived growth factor receptors as oncoproteins. Semin Oncol. 2004; 31(2 Suppl 6):4-11. DOI: 10.1053/j.seminoncol.2004.03.034. View

Aslan D, Oprea G, Jagush S, Gulbahce H, Adams G, Gaffney P . c-kit expression in adenoid cystic carcinoma does not have an impact on local or distant tumor recurrence. Head Neck. 2005; 27(12):1028-34. DOI: 10.1002/hed.20306. View

Andreadis D, Epivatianos A, Poulopoulos A, Nomikos A, Papazoglou G, Antoniades D . Detection of C-KIT (CD117) molecule in benign and malignant salivary gland tumours. Oral Oncol. 2005; 42(1):57-65. DOI: 10.1016/j.oraloncology.2005.06.014. View

Freier K, Flechtenmacher C, Walch A, Devens F, Muhling J, Lichter P . Differential KIT expression in histological subtypes of adenoid cystic carcinoma (ACC) of the salivary gland. Oral Oncol. 2005; 41(9):934-9. DOI: 10.1016/j.oraloncology.2005.05.005. View

10.

Seethala R, Pasha T, Raghunath P, LiVolsi V, Zhang P . The selective expression of CD43 in adenoid cystic carcinoma. Appl Immunohistochem Mol Morphol. 2008; 16(2):165-72. DOI: 10.1097/PAI.0b013e318036bf8c. View

11.

Kokemueller H, Eckardt A, Brachvogel P, Hausamen J . Adenoid cystic carcinoma of the head and neck--a 20 years experience. Int J Oral Maxillofac Surg. 2003; 33(1):25-31. DOI: 10.1054/ijom.2003.0448. View

12.

Ziprin P, Ridgway P, Pfistermuller K, Peck D, Darzi A . ICAM-1 mediated tumor-mesothelial cell adhesion is modulated by IL-6 and TNF-alpha: a potential mechanism by which surgical trauma increases peritoneal metastases. Cell Commun Adhes. 2003; 10(3):141-54. View

13.

Guerriere-Kovach P, Hunt E, Patterson J, Glembocki D, English 3rd J, Wick M . Primary melanoma of the skin and cutaneous melanomatous metastases: comparative histologic features and immunophenotypes. Am J Clin Pathol. 2004; 122(1):70-7. DOI: 10.1309/FUQH-92B0-3902-5LHG. View

14.

Verweij J, Casali P, Zalcberg J, Lecesne A, Reichardt P, Blay J . Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet. 2004; 364(9440):1127-34. DOI: 10.1016/S0140-6736(04)17098-0. View

15.

Vliagoftis H, Worobec A, Metcalfe D . The protooncogene c-kit and c-kit ligand in human disease. J Allergy Clin Immunol. 1997; 100(4):435-40. DOI: 10.1016/s0091-6749(97)70131-3. View

16.

Lai R, Weiss L, Chang K, Arber D . Frequency of CD43 expression in non-Hodgkin lymphoma. A survey of 742 cases and further characterization of rare CD43+ follicular lymphomas. Am J Clin Pathol. 1999; 111(4):488-94. DOI: 10.1093/ajcp/111.4.488. View

17.

Pimenidou A, Madden L, Topping K, Smith K, Monson J, Greenman J . Novel CD43 specific phage antibodies react with early stage colorectal tumours. Oncol Rep. 2004; 11(2):327-31. View

18.

Fordice J, Kershaw C, El-Naggar A, Goepfert H . Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg. 1999; 125(2):149-52. DOI: 10.1001/archotol.125.2.149. View

19.

Rosenstein Y, Park J, Hahn W, Rosen F, Bierer B, Burakoff S . CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1. Nature. 1991; 354(6350):233-5. DOI: 10.1038/354233a0. View

20.

Jeng Y, Lin C, Hsu H . Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma. Cancer Lett. 2000; 154(1):107-11. DOI: 10.1016/s0304-3835(00)00387-6. View